Related Experiment Video

Updated: Aug 12, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 15, 2011

The prophylaxis of fungal infections

R L Powles1, S Milliken

  • 1Leukaemia Unit, Royal Marsden Hospital, Sutton, Surrey, UK.

The Journal of Antimicrobial Chemotherapy
|July 1, 1991
PubMed

Insights

Fungal infections are increasing due to immunosuppressive therapies and organ transplantation. Antifungal prophylaxis is crucial, with new agents and approaches like amphotericin B showing promise.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Immunology

Background:

  • Increased use of immunosuppressive therapies, organ transplantation, and recognition of acquired immune deficiency syndrome (AIDS) have led to a rise in fungal infections.
  • Current methods struggle to accurately identify fungal infections early, necessitating a proactive prophylactic approach.
  • The growing incidence of fungal infections impacts nearly all medical disciplines.

Purpose of the Study:

  • To highlight the increasing challenge of fungal infections in immunocompromised patients.
  • To emphasize the need for effective antifungal prophylaxis strategies.
  • To discuss emerging antifungal agents and novel therapeutic approaches.

Main Methods:

  • Review of current medical literature on fungal infections and immunosuppressive therapies.
  • Analysis of the impact of transplantation and AIDS on fungal infection rates.
  • Evaluation of existing and developing antifungal agents and prophylactic strategies.

Main Results:

  • A significant increase in fungal infections has been observed across various medical fields.
  • Early and accurate diagnosis of fungal infections remains a challenge, leading to potential morbidity and mortality.
  • Newer, safer antifungal agents are being developed, offering improved treatment options.

Conclusions:

  • Antifungal prophylaxis is essential for managing the rising incidence of fungal infections.
  • Novel approaches, including amphotericin B and bone marrow growth factors, warrant further investigation.
  • Tailored antifungal prophylaxis recommendations are necessary, considering individual treatment center factors.

More Related Videos

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...